Freeman S - Search Results

1

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin.

Reid TR, Freeman S, Post L, McCormick F, Sze DY. Reid TR, et al. Among authors: freeman s. Cancer Gene Ther. 2005 Aug;12(8):673-81. doi: 10.1038/sj.cgt.7700819. Cancer Gene Ther. 2005. PMID: 15803147 Clinical Trial.

2

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.

Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. Hecht JR, et al. Among authors: freeman sm. Clin Cancer Res. 2003 Feb;9(2):555-61. Clin Cancer Res. 2003. PMID: 12576418 Clinical Trial.

3

Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival.

Sze DY, Freeman SM, Slonim SM, Samuels SL, Andrews JC, Hicks M, Ahrar K, Gupta S, Reid TR. Sze DY, et al. Among authors: freeman sm. J Vasc Interv Radiol. 2003 Mar;14(3):279-90. doi: 10.1097/01.rvi.0000058422.01661.1e. J Vasc Interv Radiol. 2003. PMID: 12631632

4

Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.

Nemunaitis J, Cunningham C, Tong A, Post L, Netto G, Paulson AS, Rich D, Blackburn A, Sands B, Gibson B, Randlev B, Freeman S. Nemunaitis J, et al. Among authors: freeman s. Cancer Gene Ther. 2003 May;10(5):341-52. doi: 10.1038/sj.cgt.7700585. Cancer Gene Ther. 2003. PMID: 12719704 Clinical Trial.

5

Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.

Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, Sloan JA, Atherton P, Edmonson JH, Erlichman C, Randlev B, Wang Q, Freeman S, Rubin J. Galanis E, et al. Among authors: freeman s. Gene Ther. 2005 Mar;12(5):437-45. doi: 10.1038/sj.gt.3302436. Gene Ther. 2005. PMID: 15647767 Clinical Trial.

6

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J. Chiocca EA, et al. Among authors: freeman s. Mol Ther. 2004 Nov;10(5):958-66. doi: 10.1016/j.ymthe.2004.07.021. Mol Ther. 2004. PMID: 15509513 Free article. Clinical Trial.

7

A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.

Freeman SM, Franco JL, Kenady DE, Baltzer L, Roth Z, Brandwein HJ, Hadden JW. Freeman SM, et al. Am J Clin Oncol. 2011 Apr;34(2):173-8. doi: 10.1097/COC.0b013e3181dbb9d8. Am J Clin Oncol. 2011. PMID: 20539208 Clinical Trial.

8

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.

Wolf GT, Fee WE Jr, Dolan RW, Moyer JS, Kaplan MJ, Spring PM, Suen J, Kenady DE, Newman JG, Carroll WR, Gillespie MB, Freeman SM, Baltzer L, Kirkley TD, Brandwein HJ, Hadden JW. Wolf GT, et al. Among authors: freeman sm. Head Neck. 2011 Dec;33(12):1666-74. doi: 10.1002/hed.21660. Epub 2011 Jan 31. Head Neck. 2011. PMID: 21284052 Free PMC article. Clinical Trial.

9

Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy.

Freeman SA, Zéphir H. Freeman SA, et al. Rev Neurol (Paris). 2024 Apr 9:S0035-3787(24)00474-0. doi: 10.1016/j.neurol.2023.12.013. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 38599976 Review.

10

Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity (STEP): Study protocol for a randomized controlled trial.

Smits JAJ, Zvolensky MJ, Cheney MK, Rosenfield D, Brown RA, Manser SS, Otto MW, Freeman SZ, Sarmiento MI, Thureen SE. Smits JAJ, et al. Among authors: freeman sz. Contemp Clin Trials. 2024 Apr 3;141:107521. doi: 10.1016/j.cct.2024.107521. Online ahead of print. Contemp Clin Trials. 2024. PMID: 38580103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,981 results

Search Page